Abstract:
An apparatus configured to enable the concentration of paramagnetic and/or superparamagnetic materials in a fluid for the purpose of examining such materials. The apparatus includes a magnet container arranged to be located proximate to a material container containing the materials to be examined. The magnet container includes therein a fluid and one or more magnets. The magnet container further includes means for controlling the movement of the one or more magnets in the fluid to allow the attraction of the paramagnetic and/or superparamagnetic materials in the material container to the one or more magnets as they travel in the magnet container so as to concentrate those materials. Several options for controlling the movement of the one or more magnets are described, including fluid viscosity selection, magnet shape and size selection, the use of an inclined pathway and the use of an inclined plane.
Abstract:
The disclosure relates to microfluidic devices and methods of use thereof for monitoring the directionality, velocity, and migration persistence of neutrophils or other cells in the absence of chemical gradients for the purposes of detecting and quantifying abnormal neutrophil motility phenotypes, using low sample volumes and with minimal activation of the neutrophils. The devices and methods can be used to diagnose sepsis in subjects suspected of having sepsis or at risk of developing sepsis. The devices and methods can also be used to monitor the responses of patients to sepsis therapies.
Abstract:
Provided herein is an assay for detecting a rough-type mycobacterium and a smooth-type mycobacterium in a sample, wherein the mycobacterium is Mycobacterium tuberculosis or Mycobacterium bovis . The assay comprises a first molecule that selectively binds to the rough- type mycobacterium or binds to a molecule preferentially secreted by the rough-type mycobacterium and a second molecule that selectively binds to the smooth-type mycobacterium or binds to a molecule preferentially secreted by the smooth-type mycobacterium. The first molecule and the second molecule are independently detectable. Also provided herein are corresponding methods for detecting a rough-type mycobacterium and a smooth-type mycobacterium in a sample and assays and methods for detecting tuberculosis infection in a sample.
Abstract:
This invention relates to the detection and quantification of D-dimer levels in a sample derived from a patient having or suspected of having periprosthetic joint infection (PJI) and subsequent diagnosis of PJI.
Abstract:
The invention provides diagnostic markers of immunosenescence and methods of identifying individuals with impaired immune function based on the expression level of a combination of such markers in a biological sample obtained from said individual. Such combination of markers is useful for determining the susceptibility to nosocomial infections of an individual. Such combination of markers is also useful for predicting whether an individual will respond to active vaccination and become protected against recurring diseases.
Abstract:
Disclosed are methods, apparatus, kits and compositions for determining the absence of a systemic bacterial infection (sepsis) in patients, particularly ones presenting to hospital emergency departments (ED) as outpatients, by measurement of the host immune response using peripheral blood. The are methods, apparatus, kits and compositions can be used in mammals for diagnosing, making treatment decisions, determining the next procedure or diagnostic test, or management of patients suspected of having an infection, including those presenting with fever or other signs of systemic inflammation. More particularly, peripheral blood RNA and protein biomarkers are disclosed that are useful for distinguishing between the host immune response to bacteria compared to the host immune response to other causes of systemic inflammation including trauma, burns, autoimmune disease, asthma, anaphylaxis, arthritis, obesity and viral infections. As such, the biomarkers are useful for distinguishing bacterial-associated systemic inflammatory response syndrome from non-bacterial systemic inflammation to provide clinicians with strong negative predictive value (>95%) so that sepsis can be excluded as a diagnosis in patients presenting to ED with clinical signs of systemic inflammation.
Abstract:
본 발명은 어류 에드와드 감염증과 연쇄구균 감염증 원인세균의 판별 및 검출용 유전자 마커, 및 이를 이용한 원인세균의 판별 및 검출 방법에 관한 것으로, 더욱 자세하게는 어류 에드와드 감염증과 연쇄구균 감염증 원인세균인 에드와드시엘라 타르다(Edwardsiella tarda), 연쇄구균인 스트렙토코카스 이니애( Streptococcus iniae ), 스트렙토코카스 파라우베리스( Streptococcus parauberis ) 및 락토코카스 가비에( Lactococcus garvieae )의 16S rDNA 유전자를 코딩하는 DNA 염기서열 중 세균 특이적 단일염기다형성(Single nucleotide polymorphism, SNP)을 포함하는 유전자 마커를 선정하여 증폭시킨 다음, 증폭산물을 특이적으로 인식하는 펩티드핵산(Peptide Nucleic Acid, PNA)을 혼성화시키고, 혼성화된 산물의 온도 조절을 통해 온도별 융해곡선을 얻고, 상기 얻은 융해곡선의 분석을 통해 융해온도로부터 세균 종을 판별하거나 어류의 상기 세균 종의 감염 여부를 검출하는 방법에 관한 것이다. 본 발명은 어류 질병 원인세균인 에드와드시엘라 타르다, 스트렙토코카스 이니애, 스트렙토코카스 파라우베리스 및 락토코카스 가비에의 판별 및/또는 검출용 유전자 마커를 선정하고, 상기 유전자 마커에 특이적인 펩티드핵산 및 프라이머 쌍을 이용하여 세균 종마다 서로 다른 형광의 증폭 및 융해곡선을 나타내게 함으로써 어류 질병 원인세균을 간단ㆍ신속ㆍ정확하게 판별하고, 어류의 상기 세균의 감염 여부를 검출할 수 있는 효과가 있다.
Abstract:
The present disclosure provides a polypeptide for detection of pathogenic mycobacteria in a biological sample. Also provided are use of said polypeptide, and method of detection of pathogenic mycobacteria in a biological sample.
Abstract:
Disclosed are compositions, methods and apparatus for diagnosing and/or monitoring a virus-associated systemic inflammation by measurement of a host immune response. The invention can be used for diagnosis including early diagnosis, monitoring, making treatment decisions, or management of subjects suspected of having systemic inflammation associated with an infection. More particularly, the present disclosure relates to peripheral blood RNA and protein biomarkers that are useful for specifically distinguishing between the host systemic immune response to viruses as compared to the host immune response to other causes of systemic inflammation.
Abstract:
Methods of detecting a local infection, critical colonization, or infection in a wound, predicting wound healing in a wound, and detecting bacterial pathogenesis in a wound are provided.